Galectin Therapeutics Inc.

NASDAQ:GALT

Biotechnology

Healthcare
$2.98 +1.62%

+$0.05 today

Market cap
$196.25M
Beta
0.49
P/E (TTM)
-7.1
EPS (TTM)
-$0.40
52W Low $1.85High $7.13

Volume 0.23M

Average 0.32M

Balance Sheet

Inspect the capital base behind the business.

Assets

$19.53M

FY 2025 · Annual

+11.6% YoY

Liabilities

$145.73M

FY 2025 · Annual

+20.9% YoY

Equity

-$126.19M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents39.65M18.59M25.66M15.12M17.72M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets2.17M1.96M2.05M2.13M1.72M
Total Current Assets41.82M20.55M27.71M17.25M19.44M
Property, Plant & Equipment (Net)0053K00
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets7K733K437K243K96K
Total Non-current Assets7K733K490K243K96K
Total Assets41.83M21.29M28.2M17.5M19.53M
Account Payables1.81M3.89M6.43M5.66M3.25M
Short-term Debt00021.12M0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.49M8.11M8.07M1.89M1.06M
Total Current Liabilities9.03M13.01M15.68M35.41M8.03M
Long-term Debt29.05M39.83M71.74M85.11M133.74M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.13M639K1M47K3.96M
Total Non-current Liabilities30.18M40.47M72.77M85.16M137.7M
Total Liabilities39.21M53.48M88.44M120.57M145.73M
Common Stock59K59K61K62K65K
Retained Earnings(270.69M)(309.57M)(354.37M)(401.57M)(432.55M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity2.62M(32.19M)(60.24M)(103.07M)(126.2M)
Total Debt29.06M39.87M71.81M106.25M133.76M
Net Debt(10.59M)21.28M46.15M91.13M116.04M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$14.1M
Other Current$1.6M
Total Current Assets$15.7M
Other Non-current$68.0K
Total Non-current Assets$68.0K
Total Assets$15.8M

Analysis

Selected assets total $15.8M for Latest. The largest visible component is Cash & Equivalents at $14.1M, about 89.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
ARSARS filingOct 13, 2026
DEF 14ADEF 14A filingOct 13, 2026
DEFA14ADEFA14A filingOct 13, 2026
PRE 14APRE 14A filingOct 2, 2026
10-QQuarterly reportAug 14, 2026

How much cash does GALT have?

Galectin Therapeutics Inc. (GALT) reported $17.72M in cash and equivalents in fiscal 2025.

How much debt does GALT carry?

Galectin Therapeutics Inc. (GALT) reported $133.76M of total debt, with net debt of $116.04M.